← Back to Clinical Trials
RecruitingNCT06905223

A Pilot Study of Synbiotics in Adults With Depressive Symptoms

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

ConditionDepressive Symptoms Mild to Moderate in Severity
SponsorGenieBiome Limited
Study TypeINTERVENTIONAL
PhaseN/A
Enrollment30
SexALL
Min Age18 Years
Max AgeN/A
Start Date2025-04-03
Completion2026-03-25
Interventions
MQU10

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study aims to explore the efficacy and safety of a synbiotic formula (MQU10) in improving mood and well-being in adults with mild to moderate depressive symptoms.

Eligibility Criteria

Inclusion Criteria: * Individuals aged 18 or above * Patient Health Questionnaire-9 (PHQ-9) score between 5 to 14 * Literate and can complete the self-report questionnaires * Able to understand the consent and sign the informed consent form Exclusion Criteria: * Current diagnosis of substance abuse or dependence; * A current or past history of bipolar disorder, manic or hypomanic episodes, schizophrenia, personality disorder, posttraumatic stress disorder (PTSD), intellectual disability, neurodegenerative disorders (e. g, Parkinson's disease) or organic mental disorder * Requiring immediate psychiatric care (e. g, imminently suicidal subjects) or have attempted suicide in the past 3 months * Use of antipsychotics, antidepressants or sedatives, unless on a stable dose in the last 4 weeks * History of severe organ failure, renal failure on dialysis, HIV infection * Active malignancy within 5 years * History of major surgery on the gastrointestinal tract, except cholecystectomy and append

Related Trials